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1. Introduction 
Spin label electron paramagnetic resonance (EPR) 
is a useful means of studying reporter group sensitivity 
to the mobility and chemical environment of its host 
molecule [ 11. In an attempt to understand the eryth- 
rocyte membranes on a molecular level, spin label 
EPR methods have been used to monitor motional 
and structural behavior of membrane proteins and 
lipids. In particular, maleimide-analogue sulfhydryl 
spin labels have been used to study the protein 
components of both normal [2-71 and abnormal [8] 
erythrocyte membranes. Conventional EPR spectra 
provide information about molecular motion in the 
fast time range of lo-“--lo-‘s. [2-6,7] while 
saturation transfer EPR monitors relatively slower 
motions in the range of 10-7-10-3s. [7]. Therefore, 
the combination of these two techniques allows us to 
detect a wide range of molecular events occurring in 
intact membranes. Up to the present time, however, 
the spin label binding sites have not been well charac- 
terized, and it is therefore difficult to associate spec- 
tral information with specific protein molecules in 
membranes. 
We have prepared spin-labelled right side out (RSO) 
vesicles both in the presence and in the absence of 
ascorbic acid, a chemical which reduces radicals to 
make spin labels EPR-silent. Since erythrocyte 
membranes are impermeable to ascorbic acid, we 
have selectively placed ascorbic acid molecules either 
inside or outside the vesicles and are therefore able to 
monitor the signals which arise from either the inner 
or from the outer surface of the vesicles. We find that 
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- 80% of the spin-label intensity arises from label 
sites at the inner membrane surface. We have also 
isolated the cytoplasmic peripheral proteins, the 
spectrin-actin complex, from spin-labelled 
membranes and have demonstrated that - 75% of the 
spin labels are attached to this complex. Thus the 
principal component for spin-labelled erythrocyte 
membranes can be associated with the spectrin-actin 
complex, and the spin-label spectra can therefore be 
used as a spectroscopic probe to study the spectrin- 
actin complex in intact erythrocyte membranes. 
2. Materials and methods 
2.1. Sample preparation 
Membrane ghosts were prepared by the methods 
in [9]. Briefly, fresh blood cells were pelleted by cen- 
trifugation and then washed 3 times with phosphate 
saline buffer. The cells were lysed using 40 vol. 5 mM 
sodium phosphate buffer at pH 8 and washed 3 times 
to give hemoglobin-free white membrane ghosts [IO]. 
RSO vesicles were prepared by the method in 
[Ill. Membranes from 2 ml packed cells were brought 
to 5 ml total vol. with 20 mOsm phosphate buffer at 
pH 7.6. This diluted sample was then passed through 
a 26 g needle 4 times to give RSO vesicles, which were 
then centrifuged at 22 000 X g for 10 min. Vesicles 
were stored in vesicle storage buffer solution (20 mM 
KC1 and 0.5 mM NaNs in 0.7 mM phosphate buffer. 
at pH 7.6). One batch of fresh RSO vesicles was made 
up with 5 mM ascorbic acid in the buffer solution in 
order to trap ascorbic acid inside RSO vesicles. 
Ascorbic acid was also added to membrane sample to 
serve as control. 
Spectrin-actin complex was prepared by the 
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methods in [ll]. White membrane ghosts were 
incubated at 37°C in low ionic strength buffer (0.3 
mM phosphate buffer at pH 7.6) to solubilize spectrin 
-actin. The insoluble components were removed by 
centrifugation. The spectrin-actin solution was con- 
centrated to - 3 mg/ml by ultrafiltration. The spin- 
labelled spectrin-actin complex was prepared similarly 
from the spin-labelled membrane ghosts (see below 
for labelling method). Sodium dodecyl sulfate (SDS)- 
polyacrylamide gel electrophoresis (by the methods 
in [ 121) was performed on all samples. The gels of 
spin-labelled samples as presented in fig.1 show good 
agreement with those of unlabelled samples as well as 
those in [ 1 I], indicating that spectrin-actin can be 
A B C 
Fig.1. SDS-polyacrylamide gel electrophoresis by the 
methods in [ 121 of spin&belled samples: (A) membrane 
sample; (B) low ionic strength extract spectrin-actin com- 
plex; (C) insoluble residue of(B). Protein concentrations of 
these samples were different. EPR experiments were per- 
formed on these samples to give results presented in table 2. 
270 
extracted from spin-labelled membrane samples as 
easily as from unlabelled membranes. 
2.2. EPR sample preparation 
Immediately after preparation, samples of RSO 
vesicles with and without ascorbic acid inside were 
labelled with N-( 1 -oxyl-2,2,6,6-tetramethyl4-piperi- 
dinyl) maleimide (Mal-6) (30-50 pg/mg protein) in 
the dark for 1 h. Membrane samples with and without 
ascorbic acid were also labelled similarly. All samples 
were then washed with the proper buffers to remove 
excess spin labels. After the third wash, EPR spectra 
were taken. Washing a particular sample was terminat- 
ed when its EPR spectrum was the same as the one 
taken after the previous wash. A portion of the spin- 
labelled RSO vesicles was incubated for 2 min at 
room temperature in 5 mM ascorbic acid and was then 
washed to remove excess ascorbic acid. Unsealed spin- 
labelled membrane sample was also incubated with 
ascorbic acid as a control in parallel with the vesicle 
sample. 
All preparations for each run were done at 4°C on 
the same day. 
2.3. RSO sideness assay 
The glyceraldehyde 3-phosphate (C 3-P) dehy- 
drogenase accessibility assay was used to determine 
the percentage of RSO vesicles in each sample. The 
procedure was that in [9] with minor variations. 
Samples consisting 10 pg Mb protein in 0.1 ml were 
preincubated for 1 min with an equal volume of 
5 mM phosphate buffer at pH 8 either with or without 
0.2% Triton X-100. Sodium pyrophosphate (30 mM) 
adjusted to pH 8.4 just before use, was added to give 
1 ml sample vol. followed by the addition of 0.03 ml 
4 M sodium arsenate and 0.05 ml 20 mM nicotinamide 
adenine dinucleotide. After the addition of 0.1 ml 
1.5 mM G 3-P at pH 7, the reaction was followed spec- 
trophotometrically (340 nm) for 75 s. The increase 
in absorbance between 15 and 75 s was taken as a 
measure of enzyme activity. Percentage of RSO 
vesicles was determined from the absorbance readings 
for the reactions in phosphate buffer with and without 
Triton X-100 buffer. The assay was carried out at 
room temperature on fresh (prepared on the same 
day) vesicles with and without ascorbic acid either 
inside or outside of the vesicles. 
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2.4. Protein determination 
Protein concentrations were determined by using 
a simplified Lowry method [ 13 1. Generally, protein 
concentration was determined on the EPR sample 
after the experiment was performed. 
2.5. EPR measurement 
The EPR measurements were carried out on a 
Varian E109E X-Band spectrometer at 20°C [7] 
immediately after the samples were prepared. Signal 
intensities were obtained directly by double integra- 
tion of the spectra with a Nicolet 535 time averager 
which was interfaced with the spectrometer. Spectral 
baselines were carefully adjusted to minimize integra- 
tion error [ 141. A spin label sample with known 
concentration was used for calibrating spin label 
concentrations from signal intensity data, 
3. Results and discussion 
The EPR spectra of erythrocyte Mb that are label- 
led with Mal 6 for 1 h in the dark at 4°C exhibit 
strongly (- 90%) and weakly (- 10%) immobilized 
components, similar to those in [4]. The spin label 
concentration is - 25 nmol labelled SH/mg protein 
(- 15 X IO-r8 mol SH/cell, assuming 6 X 10-r’ mg 
protein/cell), which is in good agreement with work 
done under similar conditions [3]. Spin-labelled 
samples of RSO vesicles give EPR spectra 
indistinguishable from those of spin-labelled 
membranes. The spectra of RSO vesicles with ascor- 
bic acid are similar to those of RSO vesicles in line 
shape but differ substantially in integrated signal 
intensity. Control samples of unsealed membranes 
which were treated with ascorbic acid in a fashion 
similar to the vesicle samples give no EPR signal. 
These results indicate that under our conditions, 
ascorbic acid effectively reduces all of the accessible 
spin labels. The total signal intensity, percentage of 
RSO vesicles, and total protein concentration of all 
samples were determined and the values obtained 
from a typical run are presented in table 1. The signal 
intensity of the membrane, or vesicle, sample was 
normalized to per milligram of protein. This value is 
then used to account for the contribution of EPR 
signals arising from the small amount of unsealed 
membranes in the vesicle samples. Finally the signal 
intensity of vesicles in each vesicle sample with 
ascorbic acid either inside or outside was used to cal- 
culate signal intensity per milligram of vesicle protein 
not accessible to ascorbic acid. These values are 
also presented in table 1. 
The results from RSO vesicle samples with ascorbic 
acid outside (from 4 different blood samples) indicate 
that 80 5 5% of the total EPR signal originates from 
spin labels attached to the SH groups (and possibly a 
few amino groups) which are located at the inner sur- 
face of the RSO vesicles, and are inaccessible to ascor- 
bic acid reduction. The other 20 + 5% signal is re- 
duced by ascorbic acid in the external medium. RSO 
vesicle samples with ascorbic acid trapped inside the 
vesicles yield an EPR signal reduced to 10 + 2% of 
the intensity in the absence of ascorbic acid, indicating 
that - 10% of the labels are located at the outer 
membrane surface. An understanding of the remaining 
Table 1 
EPR signal intensities of Mal-6 spin-labelfed erythrocyte membrane vesicles 
treated with ascorbic acid from a typical experimental run 
- 
Signal intensity % RSO Total protein Signal intensity/ 
(arbitrary unit) vesicles cont. (mg) mg vesicle proteina 
A 86.8 84.5 5.05 17.2 
B 53.0 74.2 4.93 14.5 
C 19.0 86.1 4.75 1.9 
a See text for definition 
A, sample of spin&belled RSO vesicles 
B, sample of spin-labelled RSO vesicles with vcorbic acid outside 
C, sample of spin-labelled RSO vesicles with ascorbic acid inside 
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10% signal intensity which appears to be reduced by 
both procedures may depend on a better understand- 
ing of the molecular events occurring in the samples, 
such as the extent to which ascorbic acid penetrates 
the erythrocyte membrane bilayer, and the interaction 
between ascorbic acid and membrane proteins as well 
as the lateral diffusion of these molecules in 
membranes. However, membranes prepared with 
slightly different procedures may already introduce 
some variation of the fine structure of the membranes 
which may affect the results, and a more quantitative 
description may therefore not be worthwhile. 
In addition to determining the location of the sig- 
nal sites, we further extracted the cytoplasmic periph- 
eral proteins, the spectrin-actin complex, from 
membranes in low ionic strength medium and found, 
as shown in table 2, that N 75% of the total EPR sig 
nal arises from this complex, in good agreement with 
the vesicle studies. 
Erythrocyte membranes contain several kinds of 
proteins, and spin labelling the proteins in intact 
membranes by an alkylating reagent such as Mal-6 
might be assumed to give a heterogeneous ystem of 
labelled sulhydryl groups (and may be a small percen- 
tage of other nucleophilic groups) of all proteins, 
with EPR and saturation transfer EPR spectra of these 
samples providing only general information about 
the protein system. Therefore, most of the previous 
EPR studies have suggested wide-spread protein invol- 
vement in their studies [2-681. However, our studies 
indicate that - 80% of the labelled sites are on the 
cytoplasmic (inner) surface of the intact erythrocyte 
membranes, and that ‘v 75% of the total labelled sites 
belong to the spectrin-actin complex. Other studies 
using impermeable SH reagents have also indicated 
that only a small amount (- 3%) of the erythrocyte 
membrane SH groups reside at the exofacial membrane 
surface [ 151. Early N-ethyl maleimide (NEM) studies 
indicated that 50% of the total NEM was associated 
with the spectrin-actin complex [ 161. Although 
Table 2 
EPR signal intensity of membranes and low ionic 
strength extract spectrin-actin complex 
- 




44 f 1 
33 c 1 
Mal-6 is a derivative of NEM, the two molecules are 
stereochemically quite different from each other and 
we would expect the two compounds to have only 
qualitatively, but not quantitatively similar reactivity 
with the erythrocyte membranes. Furthermore, in the 
earlier NEM studies, membranes were incubated with 
NEM at 37’C [ 161 and in our studies membranes were 
incubated with Mal-6 at 4°C. Both the lower tempera- 
ture and the larger size of the Mal-6 molecule lead us 
to expect that Mal-6 would interact less with the 
relatively buried SH groups. Thus, under our labelling 
conditions, we have selectively labelled relatively more 
of the spectrin-actin complex. This finding allows us 
to reexamine some of the previous EPR studies and 
suggest hat, for example, the calcium and pH effects 
reported [2,6] are primarily related to the spectrin- 
actin complex as reported [ 171. The spectral changes 
which were observed may be related only to specific 
changes in the spectrin-actin complex and are not 
necessarily related to wide-spread lipid mobility 
and molecular packing. 
The present studies do not allow us to comment in 
detail upon the microenvironment and chemical nature 
of the labelled sites. However, we suggest hat studies 
involving specific modifications of the spectrin-actin 
network may provide useful information about these 
label sites in the future. At the same time, the present 
studies provide a unique spectroscopic probe for 
monitoring the general molecular proporties of the 
spectrin,actin complex in intact membranes [7] 
and exploring under various conditions, the molecular 
arrangement and dynamics of these proteins, which 
are believed to control the biconcave shape of the 
erythrocyte [ 18,191. 
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